Medsource Polskasp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-09-13
Share capital
150 000,00 PLN
Activity description

Medsource Polska is a provider of decentralized clinical trial services across Europe, specializing in bringing clinical research directly to patients' homes. The company offers a network of qualified clinical research nurses who conduct home visits for study-related services, including blood sample collection and patient health monitoring. With over 15 years of experience, Medsource Polska collaborates with pharmaceutical companies and CROs to enhance the efficiency of clinical research.

Registered address
Mickiewicza 20 A/2, 80-425 Gdańsk, Poland
Website
medsource.com.plWebsite active
Email
Email address current
Phone
Social media

Financials

Revenue history (in k)

Financial insight

  • companies.financials.estonianCitCertain

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.62mMedianUSD 72.17kAverageUSD 3.11m
Net profit
This companyUSD 0.00MedianUSD 69.14AverageUSD 80.67k
Operating costs
This companyUSD 1.09mMedianUSD 75.48kAverageUSD 2.93m
Assets
This companyUSD 385.86kMedianUSD 121.09kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2000-07-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

5 public aid cases recorded, with a total value of $23,304.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$280
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$280
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$20,770

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Tomasz Jakub Kabata – President of the Management Board
Monika Maria Jaśkiewicz – Management Board Member
Wanda Kabata – Management Board Member

Manner of representation

The following persons are authorised to submit declarations of will concerning the company's property and non-property rights and obligations and to sign on behalf of the company: the President of the Management Board of the company independently, or two members of the management board jointly, or one member of the management board and a commercial proxy.

Ownership

OwnerSharesShare valueStake
Teresa Maria Brodniewicz Proba (77)
24$3,241.498%
Jerzy Bucior (80)
24$3,241.498%
Krystyna P Drewnowska
24$3,241.498%
Zenon Bolesław Jakubowski (78)
24$3,241.498%
Janusz Piotr Kabata (73)
60$8,103.7320%
Wanda Kabata (72)
144$19,448.9548%

Wanda Kabata and Janusz Piotr Kabata hold a combined 68% – the ownership structure indicates family control.

Beneficial owners

Person

Competitors

Name
GenomedS.A.
Sidlysp. z o.o.
Clinchoicesp. z o.o.
Aurevia Polandsp. z o.o.
BiokineticaS.A.
Saventic Healthsp. z o.o.
MPR Labssp. z o.o.
CTI Clinical Trial And Consulting Services Polandsp. z o.o.
Proper Medical Writingsp. z o.o.
CCTSsp. z o.o.

Change history

DateEvent
2021-04-13PKD change
2007-07-23Address change
2005-01-14Share capital change
2004-05-05Share capital change
2002-09-13Entered in the register

FAQ

Last updated: 2026-07-16